The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of sociodemographic and clinicopathological features and associated outcomes of patients (Pts) with anal squamous cell cancer (ASCC): Analysis of 44,084 pts in the National Cancer Database (NCDB).
 
Joanna Alyse Young
No Relationships to Disclose
 
Sally Jeanne Trufan
No Relationships to Disclose
 
William Mills Worrilow
No Relationships to Disclose
 
Laura W. Musselwhite
No Relationships to Disclose
 
Reza Nazemzadeh
Stock and Other Ownership Interests - Amgen; Constellation Pharmaceuticals; Exelixis; Johnson & Johnson
 
Kunal C. Kadakia
No Relationships to Disclose
 
Seungjean Chai
Consulting or Advisory Role - Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health
 
John Stuart Salmon
Stock and Other Ownership Interests - Abbvie; Agenus; Agios; Array BioPharma; Bluebird Bio; Bristol-Myers Squibb
Research Funding - Bayer (Inst)
 
Jimmy J. Hwang
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Centers of Excellence; Eisai; Genentech/Roche; Ipsen; Lilly; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Genentech/Roche; Ipsen
Research Funding - Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst)
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Research Funding - Boehringer Ingelheim; Genentech/Roche; Ignyta; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Merck; Pfizer; Takeda
 
Derek Raghavan
Consulting or Advisory Role - Caris Life Sciences (Inst); Gerson Lehrman Group
 
Mohamed E. Salem
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Taiho Pharmaceutical
Speakers' Bureau - Caris Life Sciences; Genentech/Roche; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Caris Life Sciences